var data={"title":"Congenital rubella syndrome: Clinical features and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Congenital rubella syndrome: Clinical features and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Simon R Dobson, MD, FRCP(C)</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Leonard E Weisman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Carrie Armsby, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Apr 18, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical features and diagnosis of congenital rubella infection will be reviewed here. The epidemiology of rubella infection, risk of rubella-associated congenital defects, and management of congenital rubella infection are discussed separately. (See <a href=\"topic.htm?path=rubella\" class=\"medical medical_review\">&quot;Rubella&quot;</a> and <a href=\"topic.htm?path=rubella-in-pregnancy\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;</a> and <a href=\"topic.htm?path=congenital-rubella-syndrome-management-outcome-and-prevention\" class=\"medical medical_review\">&quot;Congenital rubella syndrome: Management, outcome, and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">TERMINOLOGY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Congenital rubella infection</strong> &ndash; Congenital rubella infection (CRI) encompasses all outcomes associated with intrauterine rubella infection (eg, miscarriage, stillbirth, combinations of birth defects, asymptomatic infection) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Congenital rubella syndrome</strong> &ndash; Congenital rubella syndrome (CRS) refers to variable constellations of birth defects (eg, hearing impairment, congenital heart defects, <span class=\"nowrap\">cataracts/congenital</span> glaucoma, pigmentary retinopathy, etc) (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology of rubella infection is discussed separately. (See <a href=\"topic.htm?path=rubella-in-pregnancy#H2\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;, section on 'Epidemiology'</a> and <a href=\"topic.htm?path=rubella#H3\" class=\"medical medical_review\">&quot;Rubella&quot;, section on 'Epidemiology and vaccine development'</a>.)</p><p>CRS is rare in developed countries with established rubella immunization programs [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/2-4\" class=\"abstract_t\">2-4</a>]. It is no longer endemic in the United States, although a few cases are reported to the National Congenital Rubella Syndrome Registry each year (<a href=\"image.htm?imageKey=PEDS%2F70446%7EPEDS%2F89568\" class=\"graphic graphic_figure graphicRef70446 graphicRef89568 \">figure 1A-B</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/2,5,6\" class=\"abstract_t\">2,5,6</a>]. These cases typically occur in infants whose mothers emigrated from countries without rubella immunization programs. Following a 15-year initiative involving widespread immunization, rubella was declared in 2015 to have been eliminated from the whole of the Americas region [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>In other parts of the developing world, rubella control is accelerating through widespread implementation of rubella-containing vaccines in programs. The Global Vaccine Action Plan was endorsed by the World Health Assembly in 2012. Reported rubella cases declined by 95 percent, from 670,894 cases reported to the World Health Organization in 2000 from 102 member states, to 33,068 cases reported in 2014 from 162 member states. Rubella and further CRS elimination goals have been established [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Maternal-fetal transmission of rubella virus occurs via hematogenous spread during maternal viremia, which usually occurs five to seven days after maternal inoculation. After infecting the placenta, the virus spreads through the vascular system of the developing fetus. The resulting congenital defects stem from cytopathic damage to blood vessels and ischemia in affected organs [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/9-12\" class=\"abstract_t\">9-12</a>]. Fetal infection is chronic, persisting throughout gestation and after birth.</p><p>The risk of maternal-fetal transmission varies depending upon the time of maternal infection, with the highest risk in the first 10 weeks of gestation. The clinical manifestations also vary depending upon the time of maternal infection. Structural cardiac and eye defects typically result when maternal infection occurs before eight weeks, whereas hearing loss may be observed in maternal infections until 18 weeks gestation [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/13,14\" class=\"abstract_t\">13,14</a>]. Congenital defects are unlikely if maternal infection occurs after 18 to 20 weeks gestation. (See <a href=\"topic.htm?path=rubella-in-pregnancy#H6\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;, section on 'Congenital rubella syndrome'</a>.)</p><p>There are two proposed mechanisms for rubella cytopathology: virus-induced inhibition of cell division and direct cytopathic effects. Support for virus-induced inhibition of cell division is provided by observations that organs of congenitally infected infants are smaller and contain fewer cells than those of uninfected infants [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/15\" class=\"abstract_t\">15</a>], mitotic activity is depressed in congenitally infected embryonic primary cell cultures [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>], cell division is slowed in human fetal cells and BHK-21 cells that have been infected with rubella virus in vitro [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/16-18\" class=\"abstract_t\">16-18</a>], and a protein extracted from rubella virus-infected human fetal cells inhibits mitosis in uninfected cells [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Support for direct cytopathic effects is provided by an in vitro study demonstrating variable degrees of rubella virus-induced programmed cell death (apoptosis) in different cell lines [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. These findings suggest that programmed cell death depends upon unique cellular properties and may provide an explanation for selective organ damage in CRS. Subsequent studies demonstrating cell-specific rubella virus-induced apoptosis (in chorionic villi explants, monolayers of cytotrophoblasts, and adult lung fibroblasts, but not in primary human fetal fibroblasts) may help to explain the persistence of virus in CRS [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Other possible explanations for the persistence of rubella virus in CRS include defects in cell-mediated immunity and selective immune tolerance to the rubella virus E1 protein [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23-25\" class=\"abstract_t\">23-25</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">IMMUNOLOGIC RESPONSE</span></p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Humoral response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During the first one-half of gestation, only 5 to 10 percent of maternal immunoglobulin G (IgG) rubella antibody is passively transferred to the fetus. The fetus's own immunoglobulin M (IgM), IgG, and immunoglobulin A (IgA) appear at 9 to 11 weeks of gestation, but circulating fetal antibody levels remain low. Fetal antibody levels increase at mid-gestation, with predominance of IgM. At the time of delivery, IgG predominates and is mainly of maternal origin; IgM levels are lower but entirely of fetal origin [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/26\" class=\"abstract_t\">26</a>].</p><p>At three to five months of age, maternally derived IgG decreases and infant IgM increases. In children with congenital rubella infection (CRI), rubella-specific IgM generally persists for at least six months, often persists for up to one year, and occasionally persists for up to two years [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]. High levels of infant rubella-specific IgG antibody usually are sustained for several years after detectable rubella virus excretion ends. Over time, rubella-specific antibody levels decrease [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]; in 10 to 20 percent of patients, they may become undetectable [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/28-31\" class=\"abstract_t\">28-31</a>].</p><p>Some patients with CRI have a relative hypergammaglobulinemia (particularly of IgM and IgG) during the first few years of life, which results from the increased antigenic stimulus accompanying the chronic infection [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. There are a few case reports of hypogammaglobulinemia following intrauterine rubella infection, which usually affects only IgA, but may involve IgG, IgM, and IgA [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32,33\" class=\"abstract_t\">32,33</a>]. Alternatively, IgG may be decreased and IgM increased (two to three times normal adult levels) with or without abnormalities in IgA [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H40076903\"><span class=\"h3\">Lack of booster response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with CRI who have lost detectable rubella-specific antibody do not develop a boost in antibody titer after rubella vaccination [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/29,34\" class=\"abstract_t\">29,34</a>]. This may reflect immunologic tolerance following intrauterine exposure to rubella virus. The mechanism of immune tolerance is not known but may be related to selective tolerance to the rubella virus E1 protein or the immaturity of the fetal immune system during the first trimester of gestation [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/25,35\" class=\"abstract_t\">25,35</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Cellular response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Defects in cell-mediated immunity and persistent T cell abnormalities have been reported in patients with CRI, particularly when infection occurs early in gestation [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/24,36-39\" class=\"abstract_t\">24,36-39</a>]. Delayed type hypersensitivity reactions, lymphocyte mediated cytotoxicity, phytohemagglutinin-induced lymphocyte transformation, and interferon production are decreased compared with responses in individuals with postnatal rubella infection. T cell abnormalities may predispose patients with CRI to develop organ-specific autoimmunity.</p><p class=\"headingAnchor\" id=\"H40076910\"><span class=\"h3\">Possible role in autoimmunity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CRI is associated with increased risk for diabetes and thyroid disease. (See <a href=\"#H12\" class=\"local\">'Late manifestations'</a> below.) Patients with CRI have a high prevalence of pancreatic islet cell surface antibodies and antithyroid antibodies, suggesting that immune-mediated mechanisms may play a role in the development of diabetes and thyroid disease. However, there is no clear evidence that congenital rubella predisposes to subsequent autoimmunity. Approximately 20 percent of patients with CRS have pancreatic islet cell surface antibodies, but pancreatic islet cell antibodies (which are more closely related to immune-mediated diabetes) have not been detected [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/40-42\" class=\"abstract_t\">40-42</a>]. This suggests that other factors, such as human leukocyte antigen (HLA) type, are also important in the development of type 1 diabetes in patients with CRI [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/40,41,43-46\" class=\"abstract_t\">40,41,43-46</a>]. (See <a href=\"topic.htm?path=pathogenesis-of-type-1-diabetes-mellitus\" class=\"medical medical_review\">&quot;Pathogenesis of type 1 diabetes mellitus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital rubella infection (CRI) may lead to fetal death in utero, preterm delivery, or congenital defects [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. CRI is a chronic infection and has a broad spectrum of clinical manifestations that may manifest throughout life (<a href=\"image.htm?imageKey=PEDS%2F75721\" class=\"graphic graphic_table graphicRef75721 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,47\" class=\"abstract_t\">1,47</a>].</p><p>Deafness, cataracts (<a href=\"image.htm?imageKey=PEDS%2F64979\" class=\"graphic graphic_picture graphicRef64979 \">picture 1</a>), and cardiac disease are the classic manifestations of CRS [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/48,49\" class=\"abstract_t\">48,49</a>]. However, rubella virus may infect virtually every fetal organ [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. Once CRI is established, it can persist for long periods. (See <a href=\"#H13\" class=\"local\">'Viral shedding'</a> below.)</p><p>The manifestations of CRI vary depending upon the timing of maternal infection. The incidence of defects may be as high as 80 to 85 percent if maternal rubella is acquired during the first trimester [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/13,28,50\" class=\"abstract_t\">13,28,50</a>]. Little, if any, risk of congenital defects is associated with infection after 18 to 20 weeks gestation [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/13,51\" class=\"abstract_t\">13,51</a>]; fetal growth restriction may be the only sequela of third-trimester infection [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/28,52-54\" class=\"abstract_t\">28,52-54</a>]. (See <a href=\"topic.htm?path=rubella-in-pregnancy#H6\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;, section on 'Congenital rubella syndrome'</a>.)</p><p>The majority of infants with CRI are asymptomatic at birth but develop manifestations over time (<a href=\"image.htm?imageKey=PEDS%2F75721\" class=\"graphic graphic_table graphicRef75721 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/55-58\" class=\"abstract_t\">55-58</a>]. In prospective surveillance of 4005 infants born after the 1964 rubella epidemic in the United States, 68 percent of infected newborns had subclinical infection during the neonatal period [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/55\" class=\"abstract_t\">55</a>]. However, 71 percent of those who were followed developed clinical manifestations in the first five years of life. The lack of clinical manifestations during the newborn period and the risk for progression highlight the importance of timely diagnosis and appropriate short- and long-term management [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. (See <a href=\"topic.htm?path=congenital-rubella-syndrome-management-outcome-and-prevention\" class=\"medical medical_review\">&quot;Congenital rubella syndrome: Management, outcome, and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">In neonates</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Manifestations of CRI during the neonatal period may include (<a href=\"image.htm?imageKey=PEDS%2F75721\" class=\"graphic graphic_table graphicRef75721 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/14,23,50,59\" class=\"abstract_t\">14,23,50,59</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fetal growth restriction</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Meningoencephalitis, large anterior fontanelle</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hearing loss</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cloudy cornea, cataract (<a href=\"image.htm?imageKey=PEDS%2F64979\" class=\"graphic graphic_picture graphicRef64979 \">picture 1</a>), infantile glaucoma, retinopathy (<a href=\"image.htm?imageKey=PEDS%2F70003\" class=\"graphic graphic_picture graphicRef70003 \">picture 2</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Interstitial pneumonia (see <a href=\"topic.htm?path=neonatal-pneumonia\" class=\"medical medical_review\">&quot;Neonatal pneumonia&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiac defects</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatosplenomegaly, jaundice, hepatitis, diarrhea</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiolucent bone lesions (in the long bones)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Petechiae and purpura (&quot;blueberry muffin lesions&quot;) (<a href=\"image.htm?imageKey=PEDS%2F69581\" class=\"graphic graphic_picture graphicRef69581 \">picture 3</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adenopathy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemolytic anemia, thrombocytopenia</p><p/><p>Many of these manifestations are transient and not necessarily specific for CRI [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. They typically clear spontaneously over days or weeks. However, they may have important diagnostic and prognostic implications. The risk of mortality is increased in neonates with severe defects (eg, extreme prematurity, extensive meningoencephalitis, gross cardiac lesions or myocarditis with early heart failure, fulminant interstitial pneumonitis, and rapidly progressive hepatitis) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/14\" class=\"abstract_t\">14</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">In infants and children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Structural defects in infants and children with CRS include hearing loss, cardiac and vascular anomalies, eye lesions, and central nervous system (CNS) abnormalities [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. These generally result from defective organogenesis or scarring. (See <a href=\"#H4\" class=\"local\">'Pathogenesis'</a> above.)</p><p>Nearly two-thirds of children with intrauterine rubella infection have long-term deafness, which is usually bilateral and sensorineural [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=hearing-impairment-in-children-evaluation\" class=\"medical medical_review\">&quot;Hearing impairment in children: Evaluation&quot;</a>.)</p><p>Approximately one-half of children infected during the first two months of gestation have congenital heart disease [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Patent ductus arteriosus and branch pulmonary artery stenosis are the most common lesions [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>]. Other lesions, including pulmonary valvular stenosis, aortic valve stenosis, ventricular septal defect, tetralogy of Fallot, and coarctation of the aorta, have been reported [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/47,60\" class=\"abstract_t\">47,60</a>]. Stenosis of other vessels may be related to coronary, cerebral, renal, and peripheral vascular disease during adulthood [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61,62\" class=\"abstract_t\">61,62</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-patent-ductus-arteriosus-in-term-infants-children-and-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of patent ductus arteriosus in term infants, children, and adults&quot;</a> and <a href=\"topic.htm?path=valvar-aortic-stenosis-in-children\" class=\"medical medical_review\">&quot;Valvar aortic stenosis in children&quot;</a> and <a href=\"topic.htm?path=pathophysiology-clinical-features-and-diagnosis-of-tetralogy-of-fallot\" class=\"medical medical_review\">&quot;Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot&quot;</a>.)</p><p>Cataracts occur in approximately one-quarter of infants with CRS; infantile glaucoma is less frequent [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Cataracts and infantile glaucoma usually become apparent during the early weeks of life. &quot;Salt and pepper&quot; retinopathy (<a href=\"image.htm?imageKey=PEDS%2F70003\" class=\"graphic graphic_picture graphicRef70003 \">picture 2</a>) is caused by disturbed growth of the pigmentary layer of the retina [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/14,32\" class=\"abstract_t\">14,32</a>]. (See <a href=\"topic.htm?path=cataract-in-children\" class=\"medical medical_review\">&quot;Cataract in children&quot;</a> and <a href=\"topic.htm?path=overview-of-glaucoma-in-infants-and-children#H9\" class=\"medical medical_review\">&quot;Overview of glaucoma in infants and children&quot;, section on 'Secondary glaucoma'</a>.)</p><p>CNS abnormalities may include microcephaly (27 percent) and intellectual disability (13 percent). Motor delay, behavioral disorders, autism, and psychiatric disorders are less common [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/14,32\" class=\"abstract_t\">14,32</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Late manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Delayed manifestations of CRI occur in at least 20 percent of children with symptomatic CRI [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. Some of the late manifestations may relate to subtle damage that is present but not detected in early life. Late manifestations include [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hearing loss</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endocrine disorders</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eye problems</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vascular effects</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Progressive panencephalitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immune defects</p><p/><p class=\"headingAnchor\" id=\"H28489670\"><span class=\"h3\">Hearing loss</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Permanent hearing loss is the most common late manifestation of CRI, ultimately occurring in up to 80 percent of patients [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. Hearing loss is usually sensorineural and bilateral. It ranges in severity from mild to profound and may progress over time. Rarely, sudden onset of hearing loss may occur after years of normal hearing [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/63,64\" class=\"abstract_t\">63,64</a>].</p><p class=\"headingAnchor\" id=\"H28489677\"><span class=\"h3\">Endocrine disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Late manifestations of intrauterine rubella infection may include diabetes, thyroid disease, and growth hormone deficiency [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>].</p><p>Long-term follow-up of patients with CRS following the 1941 rubella epidemic in Australia indicated that 20 percent (9 of 44) had overt or latent diabetes by the age of 25 years and 22 percent had type 2 diabetes by age 50 to 60 years (compared with a background prevalence of 13 percent) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/56,65\" class=\"abstract_t\">56,65</a>]. More recent case series suggest that approximately 1 percent of individuals with CRI develop diabetes in childhood and adolescence [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/42,66-68\" class=\"abstract_t\">42,66-68</a>]. (See <a href=\"topic.htm?path=pathogenesis-of-type-1-diabetes-mellitus#H17\" class=\"medical medical_review\">&quot;Pathogenesis of type 1 diabetes mellitus&quot;, section on 'Role of viruses'</a>.)</p><p>Thyroid dysfunction affects approximately 5 percent of patients with CRS. It manifests as hyperthyroidism, hypothyroidism, and thyroiditis [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/69-73\" class=\"abstract_t\">69-73</a>]. A high prevalence of thyroid microsomal or thyroglobulin antibodies has been observed in patients with CRS, suggesting that immune-mediated mechanisms may play a role, but there is no clear evidence that congenital rubella predisposes to autoimmunity. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hyperthyroidism-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents&quot;</a> and <a href=\"topic.htm?path=acquired-hypothyroidism-in-childhood-and-adolescence\" class=\"medical medical_review\">&quot;Acquired hypothyroidism in childhood and adolescence&quot;</a> and <a href=\"#H6\" class=\"local\">'Humoral response'</a> above.)</p><p>CRS may occasionally be related to growth hormone deficiency and short stature [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/74\" class=\"abstract_t\">74</a>]. (See <a href=\"topic.htm?path=diagnosis-of-growth-hormone-deficiency-in-children\" class=\"medical medical_review\">&quot;Diagnosis of growth hormone deficiency in children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28489684\"><span class=\"h3\">Eye problems</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Late-onset ophthalmologic manifestations of CRS may include pigmentary retinopathy (in approximately 40 to 60 percent of cases) (<a href=\"image.htm?imageKey=PEDS%2F70003\" class=\"graphic graphic_picture graphicRef70003 \">picture 2</a>), cataracts, glaucoma (in 2 to 15 percent of cases), keratic precipitates, keratoconus, corneal hydrops, microphthalmos (estimated to occur in 10 to 20 percent of cases), strabismus, and absorption of the cataractous lens [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61,75,76\" class=\"abstract_t\">61,75,76</a>]. This damage can appear years or even decades after birth [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H28489691\"><span class=\"h3\">Vascular effects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vascular sequelae of CRS may include fibromuscular proliferation of the intima, sclerosis of arteries, systemic hypertension secondary to renal disease, and subretinal neovascularization [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61,62\" class=\"abstract_t\">61,62</a>]. These lesions are potential causes of coronary, cerebral, and peripheral vascular disease in adulthood.</p><p class=\"headingAnchor\" id=\"H28489698\"><span class=\"h3\">Panencephalitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Progressive rubella panencephalitis most commonly occurs in the second decade of life [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/77,78\" class=\"abstract_t\">77,78</a>]. It is slowly progressive and fatal. The initial findings are usually learning problems and ataxia.</p><p class=\"headingAnchor\" id=\"H28489705\"><span class=\"h3\">Immune defects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Defects in specific antibody production, repeated infections, and defective T-cell response with associated autoimmune phenomena have been observed in patients with CRS [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/79,80\" class=\"abstract_t\">79,80</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Viral shedding</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>After fetal infection, rubella virus persists throughout gestation and for months postnatally. It can be recovered from multiple sites.</p><p>Pharyngeal shedding of rubella virus is common, prolonged, and intense during the months after delivery. At one year of age, as many as 20 percent of infants with CRS continue to shed rubella virus in the pharynx, but by two years of age, pharyngeal shedding is rare [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/50,81-85\" class=\"abstract_t\">50,81-85</a>].</p><p>In patients with ocular and CNS involvement (eg, cataracts, late subacute panencephalitis), rubella virus has been cultured from the crystalline lens and cerebrospinal fluid in children older than one year of age [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/78,81,86,87\" class=\"abstract_t\">78,81,86,87</a>].</p><p class=\"headingAnchor\" id=\"H263857150\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital rubella must be differentiated from other intrauterine infections (<a href=\"image.htm?imageKey=PEDS%2F76743\" class=\"graphic graphic_table graphicRef76743 \">table 3</a>) and other conditions that have similar manifestations in the newborn, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital toxoplasmosis (see <a href=\"topic.htm?path=congenital-toxoplasmosis-clinical-features-and-diagnosis#H11762879\" class=\"medical medical_review\">&quot;Congenital toxoplasmosis: Clinical features and diagnosis&quot;, section on 'Evaluation and diagnosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital cytomegalovirus (see <a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis#H9542619\" class=\"medical medical_review\">&quot;Congenital cytomegalovirus infection: Clinical features and diagnosis&quot;, section on 'Clinical manifestations'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital herpes simplex virus (see <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H11\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Evaluation and diagnosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital syphilis (see <a href=\"topic.htm?path=congenital-syphilis-clinical-features-and-diagnosis#H28809398\" class=\"medical medical_review\">&quot;Congenital syphilis: Clinical features and diagnosis&quot;, section on 'Approach to diagnosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital Zika virus infection (see <a href=\"topic.htm?path=zika-virus-infection-evaluation-and-management-of-pregnant-women#H603468848\" class=\"medical medical_review\">&quot;Zika virus infection: Evaluation and management of pregnant women&quot;, section on 'Congenital infection'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other conditions that cause sensorineural hearing loss (see <a href=\"topic.htm?path=hearing-loss-in-children-etiology#H16\" class=\"medical medical_review\">&quot;Hearing loss in children: Etiology&quot;, section on 'Congenital'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other conditions that cause corneal clouding, including infantile glaucoma (see <a href=\"topic.htm?path=primary-infantile-glaucoma#H13\" class=\"medical medical_review\">&quot;Primary infantile glaucoma&quot;, section on 'Corneal clouding'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital heart disease (see <a href=\"topic.htm?path=identifying-newborns-with-critical-congenital-heart-disease\" class=\"medical medical_review\">&quot;Identifying newborns with critical congenital heart disease&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">EVALUATION AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Timely diagnosis of congenital rubella infection (CRI) is necessary for proper management [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. Although the diagnosis may be suspected clinically, it is confirmed with laboratory tests (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Clinical suspicion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The possibility of CRI should be considered in [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,88\" class=\"abstract_t\">1,88</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any infant born to a woman who had documented or suspected rubella infection at any time during pregnancy; treatment of maternal rubella infection with immunoglobulin does not guarantee protection from fetal infection. (See <a href=\"topic.htm?path=rubella-in-pregnancy#H9\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any infant with fetal growth restriction or other clinical manifestations of CRS (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a> and <a href=\"image.htm?imageKey=PEDS%2F75721\" class=\"graphic graphic_table graphicRef75721 \">table 2</a>) regardless of maternal history (subclinical maternal rubella infection may cause congenital malformations).</p><p/><p>In addition, newborns who fail hearing screening should undergo evaluation for rubella (measurement of rubella-specific immunoglobulin M [IgM] antibodies) and other intrauterine infections. (See <a href=\"topic.htm?path=hearing-impairment-in-children-evaluation\" class=\"medical medical_review\">&quot;Hearing impairment in children: Evaluation&quot;</a>.)</p><p>The presence of certain defects or laboratory data consistent with CRS satisfies the Centers for Disease Control and Prevention's clinical case definition (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/89\" class=\"abstract_t\">89</a>]. Cases of CRS are classified as &quot;suspected,&quot; &quot;probable,&quot; &quot;confirmed,&quot; or &quot;infection only,&quot; depending upon clinical findings and laboratory criteria for diagnosis.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The evaluation of a newborn with clinical findings compatible with intrauterine rubella infection (eg, cataract, congenital cardiac defect) is the same as the evaluation for other intrauterine infections. It should include [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,26\" class=\"abstract_t\">1,26</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Review of maternal history (evidence of rubella immunity)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Assessment of physical stigmata consistent with the syndrome (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>), including complete cardiac and neurologic examinations (see <a href=\"#H8\" class=\"local\">'Clinical features'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete blood count and platelet count</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liver function tests </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiographs of long bones</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ophthalmologic evaluation</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Audiologic evaluation</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neuroimaging (eg, ultrasonography, computed tomography) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/90\" class=\"abstract_t\">90</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lumbar puncture</p><p/><p>Some experts suggest echocardiography for all infants in whom CRS is suspected, whereas others suggest cardiology consultation and echocardiography based upon clinical examination findings [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,60\" class=\"abstract_t\">1,60</a>]. (See <a href=\"topic.htm?path=identifying-newborns-with-critical-congenital-heart-disease\" class=\"medical medical_review\">&quot;Identifying newborns with critical congenital heart disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Laboratory diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the diagnosis of CRS may be suspected clinically, it is confirmed with laboratory tests (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>].</p><p>Laboratory evaluation should be performed before the child reaches one year of age, after which it is difficult to establish a diagnosis of CRI [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/91\" class=\"abstract_t\">91</a>]. (See <a href=\"#H21\" class=\"local\">'Retrospective diagnosis'</a> below.)</p><p>Laboratory confirmation of CRI can be established through isolation of rubella virus, demonstration of rubella-specific IgM antibodies, demonstration of rubella-specific immunoglobulin G [IgG] antibodies that persist at a higher concentration or longer duration than expected from passive transfer of maternal antibody, or detection of rubella virus RNA (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/89\" class=\"abstract_t\">89</a>].</p><p>The cost, length of time required for definitive results, and expertise required for performance of these tests vary. Demonstration of rubella-specific IgM antibodies with commercially available enzyme immunoassay kits is the preferred initial test, particularly for infants in the first two months of life [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,92\" class=\"abstract_t\">1,92</a>]. Measurement of rubella-specific IgG is most helpful in infants between 6 and 12 months of age [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1,50\" class=\"abstract_t\">1,50</a>]. Consultation with an expert in pediatric infectious diseases is suggested if there are questions regarding the appropriate diagnostic strategy.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Virus isolation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of CRI can be confirmed by the isolation of the rubella virus [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Rubella virus is most frequently isolated from nasopharyngeal secretions, although it can also be cultured from blood (including cord blood), placenta, urine, and cerebrospinal fluid (CSF) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32,88\" class=\"abstract_t\">32,88</a>]. Specialized testing is necessary for rubella virus, so laboratory personnel should be notified that rubella virus is suspected [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/91\" class=\"abstract_t\">91</a>].</p><p>Virus isolation should be attempted as soon as congenital rubella is suspected, because viral excretion wanes during infancy [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. Isolation of rubella virus may be possible for several years from lens tissue in children with cataracts or CSF in children with encephalitis [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/78,86\" class=\"abstract_t\">78,86</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Serology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic confirmation of CRS consists of demonstration of rubella-specific IgM antibody or infant IgG rubella antibody level that persists at a higher level and for a longer time than expected from passive transfer of maternal antibody [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88,89\" class=\"abstract_t\">88,89</a>]. Serologic testing is more likely to be available in developing countries [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"#H6\" class=\"local\">'Humoral response'</a> above.)</p><p>Detection of rubella-specific IgM antibody in the neonatal serum or cord blood provides laboratory evidence of recent postnatal or CRI in the newborn [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23,32,88\" class=\"abstract_t\">23,32,88</a>]. IgM testing is most helpful in infants younger than two months, although IgM may be detectable for as long as 12 months in some infants [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Infants with symptoms consistent with CRS who test negative soon after birth should be retested at age one month, because approximately 20 percent of infected infants tested for rubella IgM may not have detectable titers before age one month [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>]. In infants older than two months, positive IgM is helpful, but negative IgM does not exclude infection. False-positive IgM results may be caused by rheumatoid factor, parvovirus, and heterophile antibodies [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/91\" class=\"abstract_t\">91</a>].</p><p>Monitoring rubella-specific IgG over time (eg, at 3, 6, and, if necessary, 12 months of age) also may confirm congenital or recent postnatal rubella infection if rubella-specific IgG persists at a higher level and for a longer time would be expected for maternal IgG [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88,89\" class=\"abstract_t\">88,89</a>]. Maternal rubella antibody has a half-life of approximately 30 days; it should decrease by four- to eightfold by three months of age and should disappear by 6 to 12 months of age [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/26,32,88\" class=\"abstract_t\">26,32,88</a>]. (See <a href=\"#H6\" class=\"local\">'Humoral response'</a> above.)</p><p>Monitoring rubella-specific IgG is less desirable than the other methods of laboratory diagnosis because it may delay diagnosis, does not necessarily distinguish congenital from postnatal infection, and does not absolutely exclude intrauterine infection (if the infant has low antibody levels because of agammaglobulinemia or dysgammaglobulinemia) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/26,88\" class=\"abstract_t\">26,88</a>]. In questionable cases, assessment of IgG rubella antibody avidity may be helpful [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/93,94\" class=\"abstract_t\">93,94</a>]. (See <a href=\"#H21\" class=\"local\">'Retrospective diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">Rubella virus PCR</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Detection of rubella virus RNA by polymerase chain reaction (PCR) also provides laboratory evidence of CRI [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88,89,91\" class=\"abstract_t\">88,89,91</a>] but may not be available in all settings [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. PCR may be performed on throat swabs, respiratory secretions, central nervous system tissues and CSF, amniotic fluid, and products of conception, urine samples, and lens tissue (in children with ocular anomalies) [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23,91,95-97\" class=\"abstract_t\">23,91,95-97</a>].</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Retrospective diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is difficult to establish a diagnosis of CRI in children older than one year of age [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/26,91\" class=\"abstract_t\">26,91</a>]. At this age, serologic testing usually is not diagnostic, and viral isolation is uncommon. (See <a href=\"#H18\" class=\"local\">'Virus isolation'</a> above and <a href=\"#H19\" class=\"local\">'Serology'</a> above.)</p><p>Retrospective diagnosis of CRS may be possible in children who are older than one year through:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Detection of persistent rubella RNA by PCR.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measuring lymphocyte response to rubella in vitro [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/34,98,99\" class=\"abstract_t\">34,98,99</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measuring rubella IgG avidity (strength of antigen-antibody binding); children with intrauterine rubella infection have low rubella-specific IgG avidity [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23,26,93,94,100,101\" class=\"abstract_t\">23,26,93,94,100,101</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measuring antibody response to rubella vaccination (in children with compatible manifestations but nondetectable antibody); children with CRS generally do not respond to rubella vaccination [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23,25,29,34,35\" class=\"abstract_t\">23,25,29,34,35</a>]. (See <a href=\"#H6\" class=\"local\">'Humoral response'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H22\"><span class=\"h1\">MANDATED REPORTING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cases of CRS (suspected or confirmed) in the United States should be reported to the Centers for Disease Control and Prevention through local and state health departments [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88,89\" class=\"abstract_t\">88,89</a>]. These cases should be reported as soon as they are suspected, even if laboratory confirmation is pending. Cases of CRS indicate the presence of rubella infections in the community that may previously have been unrecognized and should trigger intensified surveillance for rubella and CRS [<a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>].</p><p>Although additional information may be collected at the direction of the state health department, the report should include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Demographic information.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maternal history &ndash; Date of rubella vaccination(s); dates and results of previous serologic tests for rubella immunity; history or documentation of rubella infection during pregnancy; history of pregnancies inside and outside the United States; country of birth and length of residence in the United States; history of exposure to rubella; travel history.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical details (eg, cataracts, hearing impairment, developmental delay, type of congenital heart defect, meningoencephalitis, microcephaly).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Types and results of laboratory testing performed on mother and child.</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=rubella-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Rubella (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital rubella infection (CRI) refers to all outcomes associated with intrauterine rubella infection, including asymptomatic infection. Congenital rubella syndrome (CRS) refers to variable constellations of birth defects (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>). (See <a href=\"#H2\" class=\"local\">'Terminology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The risk of maternal-fetal transmission and clinical manifestations of CRI vary with the timing of maternal infection. (See <a href=\"#H4\" class=\"local\">'Pathogenesis'</a> above and <a href=\"topic.htm?path=rubella-in-pregnancy#H6\" class=\"medical medical_review\">&quot;Rubella in pregnancy&quot;, section on 'Congenital rubella syndrome'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CRI has a broad spectrum of clinical manifestations that may manifest throughout life (<a href=\"image.htm?imageKey=PEDS%2F75721\" class=\"graphic graphic_table graphicRef75721 \">table 2</a>). Hearing loss, cataracts (<a href=\"image.htm?imageKey=PEDS%2F64979\" class=\"graphic graphic_picture graphicRef64979 \">picture 1</a>), and cardiac disease are the classic manifestations of CRS (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>). However, rubella virus may infect virtually every fetal organ. (See <a href=\"#H8\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The possibility of CRI should be considered in any infant born to a woman who had documented or suspected rubella infection at any time during pregnancy, and any infant with fetal growth restriction or other clinical manifestations of CRS (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>), regardless of maternal history. (See <a href=\"#H15\" class=\"local\">'Clinical suspicion'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The evaluation of a newborn with clinical findings compatible with CRS should include review of maternal history for evidence of rubella immunity, assessment of physical stigmata of CRS (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>), complete blood count and platelet count, radiographs of the long bones, ophthalmologic evaluation, audiologic evaluation, neuroimaging, and lumbar puncture. (See <a href=\"#H16\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of CRI is confirmed by isolation of rubella virus in culture, demonstration of rubella-specific immunoglobulin M (IgM) antibodies, demonstration of rubella-specific immunoglobulin G (IgG) antibodies that persist at a higher concentration or longer duration than expected from passive transfer of maternal antibody, or detection of rubella virus RNA by polymerase chain reaction (<a href=\"image.htm?imageKey=PEDS%2F55913\" class=\"graphic graphic_table graphicRef55913 \">table 1</a>). (See <a href=\"#H17\" class=\"local\">'Laboratory diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the United States, cases of CRS (suspected or confirmed) should be reported to the Centers for Disease Control and Prevention through local and state health departments. (See <a href=\"#H22\" class=\"local\">'Mandated reporting'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Reef SE, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000; 31:85.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Elimination of rubella and congenital rubella syndrome--United States, 1969-2004. MMWR Morb Mortal Wkly Rep 2005; 54:279.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008. MMWR Morb Mortal Wkly Rep 2008; 57:1176.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. MMWR Morb Mortal Wkly Rep 2005; 54:175.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis 2006; 43 Suppl 3:S123.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. Rubella. In: Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book, 12th ed, Atkinson W, Wolfe S, Hamborsky J (Eds). Public Health Foundation, Washington, DC 2011. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/rubella.pdf (Accessed on August 10, 2011).</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Eurosurveillance editorial team. The Americas region declares that rubella has been eliminated. Euro Surveill 2015; 20.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2014. Wkly Epidemiol Rec 2015; 90:510.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Webster WS. Teratogen update: congenital rubella. Teratology 1998; 58:13.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Woods WA, Johnson RT, Hostetler DD, et al. Immunofluorescent studies on rubella-infected tissue cultures and human tissues. J Immunol 1966; 96:253.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Rawls WE. Congenital rubella: the significance of virus persistence. Prog Med Virol 1968; 10:238.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Rorke LB, Spiro AJ. Cerebral lesions in congenital rubella syndrome. J Pediatr 1967; 70:243.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2:781.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Cooper LZ. The history and medical consequences of rubella. Rev Infect Dis 1985; 7 Suppl 1:S2.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Naeye RL, Blanc W. Pathogenesis of congenital rubella. JAMA 1965; 194:1277.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000; 13:571.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">PLOTKIN SA, BOUE A, BOUE JG. THE IN VITRO GROWTH OF RUBELLA VIRUS IN HUMAN EMBRYO CELLS. Am J Epidemiol 1965; 81:71.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Vaheri A, Cristofalo VJ. Metabolism of rubella virus-infected BHK 21 cells. Enhanced glycolysis and late cellular inhibition. Arch Gesamte Virusforsch 1967; 21:425.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Plotkin SA, Vaheri A. Human fibroblasts infected with rubella virus produce a growth inhibitor. Science 1967; 156:659.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Duncan R, Muller J, Lee N, et al. Rubella virus-induced apoptosis varies among cell lines and is modulated by Bcl-XL and caspase inhibitors. Virology 1999; 255:117.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Adamo P, As&iacute;s L, Silveyra P, et al. Rubella virus does not induce apoptosis in primary human embryo fibroblast cultures: a possible way of viral persistence in congenital infection. Viral Immunol 2004; 17:87.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Adamo MP, Zapata M, Frey TK. Analysis of gene expression in fetal and adult cells infected with rubella virus. Virology 2008; 370:1.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Banatvala JE, Brown DW. Rubella. Lancet 2004; 363:1127.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Buimovici-Klein E, Lang PB, Ziring PR, Cooper LZ. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection. Pediatrics 1979; 64:620.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Mauracher CA, Mitchell LA, Tingle AJ. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome. J Immunol 1993; 151:2041.</a></li><li class=\"breakAll\">Cherry JD, Adachi K. Rubella virus. In: Feigin and Cherry&rsquo;s Textbook of Pediatric Infectious Diseases, 7th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.2195.</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Cradock-Watson JE, Ridehalgh MK. Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond) 1976; 76:109.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Peckham CS. Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Child 1972; 47:571.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Cooper LZ, Florman AL, Ziring PR, Krugman S. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine. Am J Dis Child 1971; 122:397.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Kenrick KG, Slinn RF, Dorman DC, Menser MA. Immunoglobulins and rubella-virus antibodies in adults with congenital rubella. Lancet 1968; 1:548.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Hardy JB, Sever JL, Gilkeson MR. Declining antibody titers in children with congenital rubella. J Pediatr 1969; 75:213.</a></li><li class=\"breakAll\">Plotkin, SA, Reef, et al. Rubella. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington, JS, Klein, JO, Wilson, CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.861.</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Plotkin SA, Klaus RM, Whitely JP. Hypogammaglobulinemia in an infant with congenital rubella syndrome; failure of 1-adamantanamine to stop irus excretion. J Pediatr 1966; 69:1085.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Hosking CS, Pyman C, Wilkins B. The nerve deaf child--intrauterine rubella or not? Arch Dis Child 1983; 58:327.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Meitsch K, Enders G, Wolinsky JS, et al. The role of rubella-immunoblot and rubella-peptide-EIA for the diagnosis of the congenital rubella syndrome during the prenatal and newborn periods. J Med Virol 1997; 51:280.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Verder H, Dickmeiss E, Haahr S, et al. Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function. Clin Exp Immunol 1986; 63:367.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Rabinowe SL, George KL, Loughlin R, et al. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 1986; 81:779.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Olson GB, South MA, Good RA. Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature 1967; 214:695.</a></li><li class=\"breakAll\">Maldonado YA. Rubella virus. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Edinburgh 2012. p.1112.</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Ginsberg-Fellner F, Witt ME, Fedun B, et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 1985; 7 Suppl 1:S170.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Viskari H, Paronen J, Keskinen P, et al. Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol 2003; 133:378.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Gale EA. Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia 2008; 51:1559.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Rubinstein P, Walker ME, Fedun B, et al. The HLA system in congenital rubella patients with and without diabetes. Diabetes 1982; 31:1088.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; 1:57.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Hy&ouml;ty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002; 45:1353.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Ou D, Jonsen LA, Metzger DL, Tingle AJ. CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility. Hum Immunol 1999; 60:652.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol 1993; 77:358.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Gregg N. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Austr 1941; 3:35.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">GREGG NM. Congenital defects associated with maternal rubella. Aust Hosp 1947; 14:7.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Cooper LZ, Krugman S. Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol 1967; 77:434.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Cradock-Watson JE, Ridehalgh MK, Anderson MJ, et al. Fetal infection resulting from maternal rubella after the first trimester of pregnancy. J Hyg (Lond) 1980; 85:381.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Peckham C. Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis 1985; 7 Suppl 1:S11.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Grillner L, Forsgren M, Barr B, et al. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis 1983; 15:321.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Enders G, Nickerl-Pacher U, Miller E, Cradock-Watson JE. Outcome of confirmed periconceptional maternal rubella. Lancet 1988; 1:1445.</a></li><li class=\"breakAll\">Schiff GM, Sutherland J, Light I. Congenital rubella. In: Prenatal Infections. International Symposium of Vienna, Thalhammer O (Ed), Georg Thieme Verlag, Stuttgart 1971. p.31.</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Forrest JM, Turnbull FM, Sholler GF, et al. Gregg's congenital rubella patients 60 years later. Med J Aust 2002; 177:664.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">McIntosh ED, Menser MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340:414.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Menser MA, Dods L, Harley JD. A twenty-five-year follow-up of congenital rubella. Lancet 1967; 2:1347.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Cooper LZ, Ziring PR, Ockerse AB, et al. Rubella. Clinical manifestations and management. Am J Dis Child 1969; 118:18.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Oster ME, Riehle-Colarusso T, Correa A. An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol 2010; 88:1.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Sever JL, South MA, Shaver KA. Delayed manifestations of congenital rubella. Rev Infect Dis 1985; 7 Suppl 1:S164.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Fortuin NJ, Morrow AG, Roberts WC. Late vascular manifestations of the rubella syndrome. A roentgenographic-pathologic study. Am J Med 1971; 51:134.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Desmond MM, Fisher ES, Vorderman AL, et al. The longitudinal course of congenital rubella encephalitis in nonretarded children. J Pediatr 1978; 93:584.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Anderson H, Barr B, Wedenberg E. Genetic disposition--a prerequisite for maternal rubella deafness. Arch Otolaryngol 1970; 91:141.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 2:332.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Shaver KA, Boughman JA, Nance WE. Congenital rubella syndrome and diabetes: a review of epidemiologic, genetic, and immunologic factors. Am Ann Deaf 1985; 130:526.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Fine PE, Adelstein AM, Snowman J, et al. Long term effects of exposure to viral infections in utero. Br Med J (Clin Res Ed) 1985; 290:509.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Takasu N, Ikema T, Komiya I, Mimura G. Forty-year observation of 280 Japanese patients with congenital rubella syndrome. Diabetes Care 2005; 28:2331.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">AvRuskin TW, Brakin M, Juan C. Congenital rubella and myxedema. Pediatrics 1982; 69:495.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Ziring PR, Fedun BA, Cooper LZ. Letter: Thyrotoxicosis in congenital rubella. J Pediatr 1975; 87:1002.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Ziring PR, Gallo G, Finegold M, et al. Chronic lymphocytic thyroiditis: identification of rubella virus antigen in the thyroid of a child with congenital rubella. J Pediatr 1977; 90:419.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Nieburg PI, Gardner LI. Letter: Thyroiditis and congenital rubella syndrome. J Pediatr 1976; 89:156.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Comas AP. Letter: Congenital rubella and acquired hypothyroidism secondary to Hashimoto thyroiditis. J Pediatr 1976; 88:1065.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Preece MA, Kearney PJ, Marshall WC. Growth-hormone deficiency in congenital rubella. Lancet 1977; 2:842.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">Duszak RS. Congenital rubella syndrome--major review. Optometry 2009; 80:36.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">O'Neill JF. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis. Trans Am Ophthalmol Soc 1998; 96:813.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Weil ML, Itabashi H, Cremer NE, et al. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med 1975; 292:994.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">Townsend JJ, Baringer JR, Wolinsky JS, et al. Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med 1975; 292:990.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Ameratunga R, Woon ST, Koopmans W, French J. Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection. J Clin Immunol 2009; 29:99.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Palacin PS, Castilla Y, Garz&oacute;n P, et al. Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl. J Paediatr Child Health 2007; 43:716.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/81\" class=\"nounderline abstract_t\">Plotkin SA, Cochran W, Lindquist JM, et al. Congenital rubella syndrome in late infancy. JAMA 1967; 200:435.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/82\" class=\"nounderline abstract_t\">Cooper LZ, Krugman S. Diagnosis and management: congenital rubella. Pediatrics 1966; 37:335.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/83\" class=\"nounderline abstract_t\">Lindquist JM, Plotkin SA, Shaw L, et al. Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. Br Med J 1965; 2:1401.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/84\" class=\"nounderline abstract_t\">Shewmon DA, Cherry JD, Kirby SE. Shedding of rubella virus in a 4 1/2-year-old boy with congenital rubella. Pediatr Infect Dis 1982; 1:342.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/85\" class=\"nounderline abstract_t\">Rawls WE, Phillips A, Melnick JL, Desmond MM. Persistent virus infection in congenital rubella. Arch Ophthalmol 1967; 77:430.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/86\" class=\"nounderline abstract_t\">Menser MA, Harley JD, Hertzberg R, et al. Persistence of virus in lens for three years after prenatal rubella. Lancet 1967; 2:387.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/87\" class=\"nounderline abstract_t\">PHILLIPS CA, MELNICK JL, YOW MD, et al. PERSISTENCE OF VIRUS IN INFANTS WITH CONGENITAL RUBELLA AND IN NORMAL INFANTS WITH A HISTORY OF MATERNAL RUBELLA. JAMA 1965; 193:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/88\" class=\"nounderline abstract_t\">Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 2001; 50:1.</a></li><li class=\"breakAll\">Rubella, congenital syndrome. 2007 case definition. http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/rubellasc2007.htm (Accessed on August 31, 2011).</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/90\" class=\"nounderline abstract_t\">Nickerson JP, Richner B, Santy K, et al. Neuroimaging of pediatric intracranial infection--part 2: TORCH, viral, fungal, and parasitic infections. J Neuroimaging 2012; 22:e52.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Rubella. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.688.</li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/92\" class=\"nounderline abstract_t\">Dimech W, Panagiotopoulos L, Marler J, et al. Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies. Clin Diagn Lab Immunol 2005; 12:1104.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/93\" class=\"nounderline abstract_t\">Fuccillo DA, Steele RW, Hensen SA, et al. Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun 1974; 9:81.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/94\" class=\"nounderline abstract_t\">Herne V, Hedman K, Reedik P. Immunoglobulin G avidity in the serodiagnosis of congenital rubella syndrome. Eur J Clin Microbiol Infect Dis 1997; 16:763.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/95\" class=\"nounderline abstract_t\">Rajasundari TA, Sundaresan P, Vijayalakshmi P, et al. Laboratory confirmation of congenital rubella syndrome in infants: an eye hospital based investigation. J Med Virol 2008; 80:536.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/96\" class=\"nounderline abstract_t\">Revello MG, Baldanti F, Sarasini A, et al. Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR. J Clin Microbiol 1997; 35:708.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/97\" class=\"nounderline abstract_t\">Bosma TJ, Corbett KM, O'Shea S, et al. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995; 33:1075.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/98\" class=\"nounderline abstract_t\">O'Shea S, Best J, Banatvala JE. A lymphocyte transformation assay for the diagnosis of congenital rubella. J Virol Methods 1992; 37:139.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/99\" class=\"nounderline abstract_t\">Iuorio JL, Hosking CS, Pyman C. Retrospective diagnosis of congenital rubella. Br Med J (Clin Res Ed) 1984; 289:1566.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/100\" class=\"nounderline abstract_t\">Thomas HI, Morgan-Capner P, Cradock-Watson JE, et al. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993; 41:196.</a></li><li><a href=\"https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis/abstract/101\" class=\"nounderline abstract_t\">Hyde TB, Sato HK, Hao L, et al. Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome. J Infect Dis 2015; 212:57.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6047 Version 26.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H23\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">TERMINOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PATHOGENESIS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">IMMUNOLOGIC RESPONSE</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Humoral response</a><ul><li><a href=\"#H40076903\" id=\"outline-link-H40076903\">- Lack of booster response</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">Cellular response</a><ul><li><a href=\"#H40076910\" id=\"outline-link-H40076910\">- Possible role in autoimmunity</a></li></ul></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">CLINICAL FEATURES</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Overview</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">In neonates</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">In infants and children</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Late manifestations</a><ul><li><a href=\"#H28489670\" id=\"outline-link-H28489670\">- Hearing loss</a></li><li><a href=\"#H28489677\" id=\"outline-link-H28489677\">- Endocrine disorders</a></li><li><a href=\"#H28489684\" id=\"outline-link-H28489684\">- Eye problems</a></li><li><a href=\"#H28489691\" id=\"outline-link-H28489691\">- Vascular effects</a></li><li><a href=\"#H28489698\" id=\"outline-link-H28489698\">- Panencephalitis</a></li><li><a href=\"#H28489705\" id=\"outline-link-H28489705\">- Immune defects</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">Viral shedding</a></li></ul></li><li><a href=\"#H263857150\" id=\"outline-link-H263857150\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">EVALUATION AND DIAGNOSIS</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">Clinical suspicion</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Evaluation</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Laboratory diagnosis</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">- Virus isolation</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Serology</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">- Rubella virus PCR</a></li></ul></li><li><a href=\"#H21\" id=\"outline-link-H21\">Retrospective diagnosis</a></li></ul></li><li><a href=\"#H22\" id=\"outline-link-H22\">MANDATED REPORTING</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H182187777\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6047|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/70446\" class=\"graphic graphic_figure\">- Rubella CRS epidemiology US</a></li><li><a href=\"image.htm?imageKey=PEDS/89568\" class=\"graphic graphic_figure\">- Cases rubella and CRS US</a></li></ul></li><li><div id=\"PEDS/6047|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/64979\" class=\"graphic graphic_picture\">- Congenital rubella cataract</a></li><li><a href=\"image.htm?imageKey=PEDS/70003\" class=\"graphic graphic_picture\">- Cong rubella retinopathy</a></li><li><a href=\"image.htm?imageKey=PEDS/69581\" class=\"graphic graphic_picture\">- Blueberry muffin lesions</a></li></ul></li><li><div id=\"PEDS/6047|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/55913\" class=\"graphic graphic_table\">- CRS case definition</a></li><li><a href=\"image.htm?imageKey=PEDS/75721\" class=\"graphic graphic_table\">- Congenital rubella ssx</a></li><li><a href=\"image.htm?imageKey=PEDS/76743\" class=\"graphic graphic_table\">- Characteristic features of congenital infections</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-hypothyroidism-in-childhood-and-adolescence\" class=\"medical medical_review\">Acquired hypothyroidism in childhood and adolescence</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cataract-in-children\" class=\"medical medical_review\">Cataract in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hyperthyroidism-in-children-and-adolescents\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-patent-ductus-arteriosus-in-term-infants-children-and-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of patent ductus arteriosus in term infants, children, and adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital cytomegalovirus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-rubella-syndrome-management-outcome-and-prevention\" class=\"medical medical_review\">Congenital rubella syndrome: Management, outcome, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-syphilis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital syphilis: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-toxoplasmosis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital toxoplasmosis: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-growth-hormone-deficiency-in-children\" class=\"medical medical_review\">Diagnosis of growth hormone deficiency in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hearing-impairment-in-children-evaluation\" class=\"medical medical_review\">Hearing impairment in children: Evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hearing-loss-in-children-etiology\" class=\"medical medical_review\">Hearing loss in children: Etiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=identifying-newborns-with-critical-congenital-heart-disease\" class=\"medical medical_review\">Identifying newborns with critical congenital heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-pneumonia\" class=\"medical medical_review\">Neonatal pneumonia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-glaucoma-in-infants-and-children\" class=\"medical medical_review\">Overview of glaucoma in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-type-1-diabetes-mellitus\" class=\"medical medical_review\">Pathogenesis of type 1 diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-clinical-features-and-diagnosis-of-tetralogy-of-fallot\" class=\"medical medical_review\">Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rubella-the-basics\" class=\"medical medical_basics\">Patient education: Rubella (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-infantile-glaucoma\" class=\"medical medical_review\">Primary infantile glaucoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rubella\" class=\"medical medical_review\">Rubella</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rubella-in-pregnancy\" class=\"medical medical_review\">Rubella in pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=valvar-aortic-stenosis-in-children\" class=\"medical medical_review\">Valvar aortic stenosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zika-virus-infection-evaluation-and-management-of-pregnant-women\" class=\"medical medical_review\">Zika virus infection: Evaluation and management of pregnant women</a></li></ul></div></div>","javascript":null}